NABRIVA THERAPEUTICS PLC's ticker is and the CUSIP is G63637113. A total of 1 filers reported holding NABRIVA THERAPEUTICS PLC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $25,000 | -50.0% | 141,508 | +18.1% | 0.00% | – |
Q1 2022 | $50,000 | -81.6% | 119,847 | -73.6% | 0.00% | – |
Q4 2021 | $272,000 | +130.5% | 454,320 | +358.1% | 0.00% | – |
Q3 2021 | $118,000 | -5.6% | 99,183 | +7.9% | 0.00% | – |
Q2 2021 | $125,000 | +681.2% | 91,939 | +832.2% | 0.00% | – |
Q1 2021 | $16,000 | -98.3% | 9,863 | -97.5% | 0.00% | – |
Q4 2020 | $956,000 | – | 395,175 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ABG Innovation Capital Partners III GP Ltd | 45,849 | $19,000 | 1.30% |
Aisling Capital Management LP | 191,028 | $80,000 | 0.04% |
Frazier Life Sciences Management, L.P. | 425,650 | $179,000 | 0.02% |
Values First Advisors, Inc. | 44,951 | $19,000 | 0.01% |
Running Point Capital Advisors, LLC | 10,000 | $4,000 | 0.00% |
Virtu Financial LLC | 79,556 | $33,000 | 0.00% |
CCG WEALTH MANAGEMENT, LLC | 10,000 | $4,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
PARAMETRIC PORTFOLIO ASSOCIATES LLC | 26,300 | $11,000 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 42,738 | $17,000 | 0.00% |